– USA, CA – Counsyl today announced the appointment of Pamela Sedmak, former president and chief executive officer of Aetna Medicaid/Dual Eligibles and current senior advisor at McKinsey & Company, to the company’s board of directors.
“We’re thrilled to have Pamela join our board and are confident in the valuable contributions she will make to Counsyl going forward,” said Ramji Srinivasan, co-founder and chief executive officer of Counsyl. “Pamela understands patient, provider and payer needs through her extensive experience working with some of the largest domestic payer organizations. Her insights and perspective will be essential for Counsyl in achieving our mission to provide actionable information that guides women and their families in making critical and timely health decisions.”
Pamela is a senior advisor at McKinsey & Company, a worldwide management consulting firm. Prior to this role, she served as president and chief executive officer at Aetna Medicaid/Dual Eligibles, a multi-billion dollar business segment with 3 million members in 17 states. Pamela also previously served as senior vice president and chief financial, strategy and innovation officer at Blue Cross Blue Shield of Minnesota and chief financial officer and chief operating officer at CareSource. Her career began at General Electric, holding general management and financial executive roles. In addition, Pamela has served on the boards of the Make-A-Wish Foundation in Minnesota, Arizona Chamber of Commerce and Anderson Alumni Council at the University of New Mexico Anderson School of Management. She has a bachelor’s degree in finance from the University of New Mexico and a master’s degree from Case Western Reserve University. Pamela was inducted into the Hall of Fame by the University of New Mexico’s Anderson School of Management.
“I’m honored to join Counsyl’s board and thrilled to provide critical insights to the company’s core business priorities, particularly as they relate to market access and reimbursement,” said Pamela Sedmak. “Through my experience, I am able to help Counsyl navigate the complex payer environment and how the company can continue to demonstrate the clinical value of Counsyl’s industry-leading genetic screening products.”
Since the company’s founding in 2007, Counsyl has championed advances in genetic screening for women and their families and has screened more than 850,000 patients, served more than 17,000 health care providers and provided more than 60,000 genetic counseling sessions.
Counsyl is committed to improving lives by providing actionable information that guides women and their families in making critical and timely health decisions. Whether it’s starting a family or evaluating risk for cancer, Counsyl’s genetic screens provide patients with early awareness about genetic conditions, so they can live informed and prepare for the future. Counsyl has screened more than 850,000 patients and served more than 17,000 healthcare professionals.
For more information : http://www.counsyl.com
- Disclaimer - News, data and statement included in this release are intended exclusively for information purposes. Product and brand names used in this release maybe trademarks or registered trade marks of their respective owners. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of this release. No data or statement in this release should be considered a recommendation for the purchase, retention or sale of the securities referred to herein.
Comments are closed.